Solution Information | help | |
Enzyme: | G2/mitotic-specific cyclin-B1 | |
inhibitor: | BDBM38959 | |
substrate: | n/a | |
Solution Type: | Aqueous | |
pH at Preparation: | n/a | |
Temp. Prep.: | n/a | |
Comments: | Assay Overview: The purpose of this assay is to determine whether compounds identified as active in a previous set of experiments entitled, "Primary cell-based high throughput screening assay for inhibitors of Wee1 degradation" (PubChem AID 1321), and that confirmed activity in a set of experiments entitled, "Confirmation cell-based high throughput screening assay for inhibitors of Wee1 degradation" (PubChem AID 1410), were non-selective inhibitors of protein degradation, as measured by inhibition of cyclin B degradation. The assay uses HeLa cells transfected with a plasmid that encodes a cyclin B-luciferase fusion protein to monitor cyclin B levels. The cyclin B-luciferase complex is rapidly turned over in these cells. As designed, compounds that inhibit cyclin B degradation will increase cyclin B-luciferase stability, leading to increased well luminescence. Compounds were tested in triplicate using a 10-point, 1:3 dilution series, starting at a nominal concentration of 50 uM. Pro | |
If you find an error in this entry please send us an E-mail |
Home |
| |
Search |
| |
Deposit |
| |
SiteMap |
| |
About us |
| |
Email us |
| |
Info |
|
©2000 BindingDB. All rights reserved. |